UBM Development AG

Original-Research: UBM Development AG (von NuWays AG): Buy

Original-Research: UBM Development AG - from NuWays AG

30.08.2024 / 09:01 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.

Classification of NuWays AG to UBM Development AG

Company Name:UBM Development AG
ISIN:AT0000815402
 
Reason for the research:Update
Recommendation:Buy
from:30.08.2024
Target price:EUR 27.00
Target price on sight of:12 months
Last rating change:
Analyst:Philipp Sennewald

Improved total output + residential recovery in sight, chg.

UBM released Q2 results, showing a steep increase in total output thanks to several disposals but still weak operating performance due to the ongoing standstill on the real estate transaction market.

Total output in Q2, which in addition to sales also refers to pro-rata sales of companies consolidated at-equity
as well as proceeds from share deals, increased by 161% yoy to € 164.1m, which was especially driven by the partial sale of the LeopoldQuartier Office project (30% stake) to a project partner. Further drivers were the disposals of the W3 – Center Wien Mitte to the co-owner as well as the office building Polezcki Madrid to a tenant. Notably, all deals were concluded at book value. Total net cash inflows from the transaction amount to € 75m in H1 (eNuW: € 50m in Q2), leading to a comfortable cash position of € 179m (FY ’23: € 152m).

Yet, Q2 sales, which only recognize signed project sales on a PoC base, only increased slightly by 13% yoy to € 22.5m (eNuW: € 24.9m) against a weak comparable base. The most significant sales contributions came from the construction progress on residential projects in Germany and the Czech Republic as well as forward sales in Austria. Yet, early indicators for a revival of the residential market were visible, as UBM sold a total of 97 units in H1, which is already exceeding the FY ’23 amount (96). On a positive note, Q2 EBITDA improved yoy to € 1m (eNuW: € -1.2m), which is mainly to the absence of negative fair value adjustments of the property portfolio. Moreover, cost for personnel reduced by 20% yoy following reduced head count.

As it remains uncertain, when the real estate market will reopen again, we still expect positive newsflow form UBM in the coming quarters. For instance, the company recently sent out the teaser for the Timber Pioneer project and so far attracted dozens of interested buyers for Frankfurt’s first hybrid-timber office building. While a disposal in H2 appears not likely due to the shortage of time, we estimate a closing in H1 ‘25e to be realistic. Furthermore, we expect the recovery in residential to accelerate going forward, driven by the increasing supply/demand imbalance. In office/light-industrial we further anticipate positive impacts from Germany’s “GebäudetypE” draft law, which is seen to simplify planning processes (i.e. more flexibility on room height, less radiators, etc.) and thus reduce total construction costs.

The shares remains a BUY with an unchanged PT of € 27 based on DDM.

You can download the research here: http://www.more-ir.de/d/30675.pdf
For additional information visit our website: www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

1978161  30.08.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1978161&application_name=news&site_id=ariva

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.